The bacterial culture media segment accounted for the largest share of the global microbiology culture market in 2014. This segment is likely to continue its increased share until 2023 due to an expected rise in application in food microbiology, pharmaceutical microbiology, and disease research.
The comprehensive agenda will include presentations from both regulatory and industry experts sharing recent case studies and developing trends in the field of pharmaceutical microbiology.
- Microbial contamination in aseptic manufacturing environments
- Risk assessments in fungal spore and bacterial spore excursions: Case studies
- Optimising rapid microbial-detection methods
- Tackling the current challenge of biofilms
- Flow cytometry technology and its applications
- Oliver Chancel, Sterility and Aseptic Process Assurance Expert, Merial SAS
2 EU REGULATORY AUTHORITY SPEAKERS:
- Michael Whaley, Senior Pharmacopoeial Scientist, MHRA
- Ingo Spreitzer, Deputy Head Section Microbial Safety, Paul Ehrlich Institut
NEW FOR 2017:
- Chris Day, Manager, Microbiology, Bristol-Myers Squibb
- Brandye Michaels, Group Leader/Senior Principal Scientist Analytical R&D, Microbiology, Pfizer
- Pratixa Patel, Microbiology Director, GSK
- Randall Thompson, Principal Scientist, Shire
- Jane Wyatt, Global Microbiology Leader, Alexion Pharmaceuticals, Inc.
- Benoit Ramond, Senior Microbiology Expert, Sanofi
Don't miss two pre-conference workshops:
A: Solutions for addressing fungal and bacterial spore contamination in pharmaceutical and biotech operations
(By STERIS Corporation and Battelle Memorial Institute)